Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cerner, the University of New Mexico Health Sciences Center College of Pharmacy, the UNM School of Engineering and STC.UNM, the University's technology-transfer corporation, have signed a sponsored research agreement to evaluate UNMHSC's dry-powder inhaler drug-delivery technology for use in both pulmonary and systemic conditions, like asthma and chronic obstructive lung disease.
Subscribe to our email newsletter
Upon completion of the research studies, the agreement provides Cerner an option for exclusive licensing of University of New Mexico Health Sciences Center’s (UNMHSC) technology for clinical and commercial use worldwide. This sponsored research agreement is said to be a clear opportunity for Cerner and UNMHSC to make a difference for people who could benefit from this new type of inhaler technology.
Douglas McNair, senior vice president for clinical research at Cerner, said: “Based upon its impressive capabilities for dispersal of particles with only small inspiratory effort, we believe UNMHSC’s DPI technology can become an important addition to the therapeutic armamentarium, especially for indications that affect children and the elderly.”